Research Article
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study
Table 1
Patient demographic and tumor histopathologic characteristics.
| Characteristics | |
| Mean age at time of diagnosis in years (range) | 54 (26–91) |
| Age groups, years, (%) | | <35 years | 41 (4.83) | 35–39 | 41 (4.83) | 40–49 | 245 (28.86) | 50–59 | 223 (26.27) | 60–69 | 172 (20.26) | ≥70 | 127 (14.96) |
| Menopausal status, (%) | (%) | Premenopausal | 496 (58.42) | Postmenopausal | 353 (41.58) |
| BMI, mean (range), (%) | 27.4 (14–49.9) | Unknown | 15 (1.7%) | <18.5 | 13 (1.53%) | 18.5–24.9 | 291 (34.28%) | 25–29 | 291 (34.28%) | ≥30 | 239 (28.15%) |
| Tumor size, (%) | (%) | TX | 25 (2.94) | T1 | 210 (24.73) | T2 | 301 (35.45) | T3 | 140 (16.49) | T4 | 173 (20.38) |
| Lymph node status, (%) | | Nx | 293 (34.51) | N0 | 304 (35.8) | N1–N3 | 252 (29.68) |
| TNM, (%) | | I | 176 (20.73) | II | 389 (45.82) | III | 228 (26.86) | IV | 32 (3.77) |
| Histological subtype, (%) | | Ductal invasive | 711 (83.7) | Lobular invasive | 57 (6.71) | Other | 37 (4.36) |
| Tumor grade, (%) | | G1 | 143 (16.84) | G2 | 375 (44.17) | G3 | 211 (24.85) |
| Estrogen receptor status, (%) | | Positive | 605 (71.26) | Negative | 244 (28.74) |
| Progesterone receptor status, (%) | | Positive | 537 (63.25) | Negative | 312 (36.75) |
| HER 2, (%) | | Positive | 211 (24.85) | Negative | 601 (70.79) | Unknown | 37 (4.36) |
| Tumor subtype (IHC4), (%) | | Luminal A | 298 (35.1) | Luminal B, HER 2− | 172 (20.26) | Luminal B, HER 2+ | 131 (15.43) | Her 2-enriched | 79 (9.31) | Triple negative | 133 (15.67) |
|
|